Exchange: NASDAQ·Updated 08:25 PM EDT
SLXN logo

SLXN Silexion Therapeutics Ltd

$0.4216
$0.0555
(14.61%)
Today
Closed $0.4355
$0.0139
(3.19%)
Overnight
Reported EarningsAug 14
Mkt Cap$2.51M
Vol27.81M

About SLXN

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
59

Bullish Sentiment

How do you feel about SLXN?

Advertisement|Remove ads.